Event

PODD: Partnership Opportunities in Drug Delivery

October 29-30, 2026
Boston, MA

Battelle is proud to be a part of the 2026 PODD conference. Stop by booth #521 to learn how we partner with clients to create innovative systems that condense the development timeline and deliver drugs to market faster.
Connect With an Expert

About PODD

Pharma, biotech and drug delivery professionals will gather at the 16th annual PODD: Partnership Opportunities in Drug Delivery conference to assess delivery needs, explore partnership opportunities, and stay at the forefront of innovative drug delivery technologies, including small molecules, biologics, combination products, connected devices, cell and gene delivery and more.

PODD also provides partnering opportunities through organized networking for new, emerging and established collaborations.

Learn More

Find Us At PODD 2026


Connect with our team at Booth #521 and be sure to attend our sessions to learn about our experts' latest breakthroughs in cell, gene and novel biologics delivery as well as novel injectable and non-injectable technologies.

 

Image: Battelle expert Gabe Meister

Gabe Meister
Research Leader, Battelle

Alternative Approaches to Achieving Effective Gene Delivery

Track 4A: Cell, Gene & Novel Biologics Delivery Pt 1


Date: Thu, Oct 29
Time: 1:30 PM - 1:45 PM
Location: Fairfax

Details: 

  1. Challenges, limitations and opportunities to deliver novel molecular therapeutics
  2. Advancements made in delivering novel molecular therapeutics when utilizing non-viral delivery platforms
  3. Novel approaches to treating rare genetic diseases and cancer


Image: Battelle expert André LaFreniere

André LaFreniere
Vice President, Medical Device Solutions, Battelle

Addressing Both Viscosity & Volume for Subcutaneous Injections

Track 3B: Novel Injectable & Non-Injectable Technologies


Date: Thu, Oct 29
Time: 4:30 PM - 4:45 PM
Location: Gardner

Details: 

Pharmaceutical pipelines include numerous candidates that are likely to be dispensed in higher volumes (greater than 5 ml) and numerous candidate therapies that are increasingly viscous (greater than 50 cP). This session seeks to answer the question of how to address the needs of those candidate therapies that are both higher volume and require increased viscosity by proposing a solution that addresses both challenges simultaneously.

Enabling Your Drug Delivery Success

Novel therapies are changing the face of medicine. Getting them safely to patients requires innovative drug delivery. When you encounter a challenge where the solution seems just out of reach, or you need a partner in innovation, Battelle’s scientists, engineers, human-centered designers, and world-class facilities can help deliver your product to market with confidence.
Explore Drug Delivery Solutions

Our Insights

View All Insights

View All Insights

Related Solutions



  • Image: Battelle medical device expert working on a new product concept solution

    Medical Device Design and Development

    Bring even the most complex devices to market with certainty. Our deep expertise and world-class facilities help you successfully navigate the stages of the product development process.
  • Photo: Engineer in the lab testing a medical devices on a dummy solution

    Medical Technologies for License

    We combine deep knowledge, world-class expertise, and specialized facilities to develop disruptive products that solve challenging problems.
  • Image: Battelle industrial designer examining a device sketch solution

    Human-Centered Design

    Bringing together designers, cognitive psychologists, scientists and engineers from multiple disciplines to design medical devices and health products that focus on human needs, capabilities and uses in the real world.
  • alt= Light micrograph (LM) of a vertical section through the pseudostratified columnar epithelium from the trachea, the tube in the throat leading from the mouth to the bronchus and the lungs solution

    New Approach Methodologies

    New approach methodologies (NAMs) apply advanced in vitro and microphysiological systems to generate earlier, more human-relevant evidence of safety, efficacy, and biological response.
  • Image: Person using an autoinjector solution

    Drug Delivery

    Novel therapies are changing the face of medicine. Getting them safely to patients requires innovative drug delivery. When you encounter a challenge where the solution seems just out of reach, or you need a partner in innovation, Battelle’s scientists, engineers, human-centered designers, and world-class facilities can deliver your product to market with confidence.